Caligiuri MA - Search Results

1

IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease.

Roychowdhury S, Blaser BW, Freud AG, Katz K, Bhatt D, Ferketich AK, Bergdall V, Kusewitt D, Baiocchi RA, Caligiuri MA. Roychowdhury S, et al. Among authors: caligiuri ma. Blood. 2005 Oct 1;106(7):2433-5. doi: 10.1182/blood-2005-04-1597. Epub 2005 Jun 23. Blood. 2005. PMID: 15976176 Free PMC article.

2

Expression of the zeta protein subunit in CD3- NK effectors derived from human thymus.

Beecher MS, Baiocchi RA, Linett ML, Krajewski CA, Caligiuri MA. Beecher MS, et al. Among authors: caligiuri ma. Cell Immunol. 1994 May;155(2):508-16. doi: 10.1006/cimm.1994.1143. Cell Immunol. 1994. PMID: 7514106

3

The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2.

Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA. Carson WE, et al. Among authors: caligiuri ma. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7553-7. doi: 10.1073/pnas.91.16.7553. Proc Natl Acad Sci U S A. 1994. PMID: 7519782 Free PMC article.

4

The functional characterization of interleukin-10 receptor expression on human natural killer cells.

Carson WE, Lindemann MJ, Baiocchi R, Linett M, Tan JC, Chou CC, Narula S, Caligiuri MA. Carson WE, et al. Among authors: caligiuri ma. Blood. 1995 Jun 15;85(12):3577-85. Blood. 1995. PMID: 7540068 Free article.

5

Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.

Baiocchi RA, Caligiuri MA. Baiocchi RA, et al. Among authors: caligiuri ma. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5577-81. doi: 10.1073/pnas.91.12.5577. Proc Natl Acad Sci U S A. 1994. PMID: 7911241 Free PMC article.

6

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro.

Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri MA. Carson WE, et al. Among authors: caligiuri ma. J Clin Invest. 1995 Dec;96(6):2578-82. doi: 10.1172/JCI118321. J Clin Invest. 1995. PMID: 8675621 Free PMC article.

7

Phenotypic and functional analysis of Fas (CD95) expression in primary central nervous system lymphoma of patients with acquired immunodeficiency syndrome.

Baiocchi RA, Khatri VP, Lindemann MJ, Ross ME, Papoff G, Caprio AJ, Caprio TV, Fenstermaker R, Ruberti G, Bernstein ZP, Caligiuri MA. Baiocchi RA, et al. Among authors: caligiuri ma. Blood. 1997 Sep 1;90(5):1737-46. Blood. 1997. PMID: 9292506 Free article.

8

Immunotherapy with low-dose interleukin-2: rationale for prevention of immune-deficiency-associated cancer.

Khatri VP, Baiocchi RA, Bernstein ZP, Caligiuri MA. Khatri VP, et al. Among authors: caligiuri ma. Cancer J Sci Am. 1997 Dec;3 Suppl 1:S129-36. Cancer J Sci Am. 1997. PMID: 9457408 Review.

9

Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.

Khatri VP, Fehniger TA, Baiocchi RA, Yu F, Shah MH, Schiller DS, Gould M, Gazzinelli RT, Bernstein ZP, Caligiuri MA. Khatri VP, et al. Among authors: caligiuri ma. J Clin Invest. 1998 Mar 15;101(6):1373-8. doi: 10.1172/JCI2038. J Clin Invest. 1998. PMID: 9502779 Free PMC article.

10

Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15.

Yu H, Fehniger TA, Fuchshuber P, Thiel KS, Vivier E, Carson WE, Caligiuri MA. Yu H, et al. Among authors: caligiuri ma. Blood. 1998 Nov 15;92(10):3647-57. Blood. 1998. PMID: 9808558 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

484 results

Search Page

Filters